View ICR - OIRA Conclusion



0910-0154 201102-0910-005
Historical Inactive 200712-0910-008
HHS/FDA
Good Manufacturing Practice Regulations for Type A Medicated Articles, 21 CFR Part 226
Extension without change of a currently approved collection   No
Regular
Improperly submitted and continue 04/25/2011
02/22/2011
In accordance with the terms of 5 CFR 1320, OMB considers this information collection request to be improperly submitted. OMB notes that this collection lists a decrease in responses of 931,500 due to error in agency estimate. The decrease is not explained in the agency's supporting statement and, thus, there is insufficient information to evaluate this request. Please resumbit with a description of how such a large error in estimate occured.
  Inventory as of this Action Requested Previously Approved
02/28/2011 36 Months From Approved 06/30/2011
1,082,150 0 1,082,150
157,550 0 157,550
0 0 0